Research Article

CRT-D Therapy in Patients with Decompensated NYHA Class-Four CHF

Table 1

Baseline demographics.

CharacteristicsValues

Total patients16 (100%)
Male10 (63%)
Age (years)
LVEF (%)
LVEDd (cm)
QRS (ms)
Ischemic cardiomyopathy11 (69%)
Impaired renal function (SCr > 1.5 mg/dL)10 (63%)
Beta blockers10 (63%)
Ace-inhibitors10 (63%)
Angiotensin receptor blockers2 (12%)
Intravenous diuretics16 (100%)
Intravenous inotropes13 (81%)
Dobutamine12 (75%)
Milrinone7 (44%)
Dopamine1 (6%)
Nesiritide3 (19%)